Drinking beet juice associated with reduced restenosis after PCI

Published Date: 02 Mar 2023

Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.

Read Full News

Latest News

Secret Shopper Study Warns About Online GLP-1 Sellers

Two-thirds of websites did not require clinician interaction before a prescription

Case Report: Cannabis and Compulsive Showering

An unexpected effect of chronic marijuana use

Chronically Short Sleep May Lead to Weight Gain in Adults With Heart Risks

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

When Endurance Training Can Be Deadly for Older Athletes

This case shows the danger of one asymptomatic condition in particular

Cardiologist Runs for Mayor; PCSK9 Inhibitor Price Drops; Pregnancy OK After AVR?

Recent developments of interest in cardiovascular medicine

ASPECTS Fails to Reflect Ceiling for Endovascular Stroke Therapy Benefit

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Two-thirds of websites did not require clinician interaction before a prescription

An unexpected effect of chronic marijuana use

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

This case shows the danger of one asymptomatic condition in particular

Recent developments of interest in cardiovascular medicine

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

News All Time

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

Visceral Fat and Cardiometabolic Risk Factors; Autoantibodies and IBD

Also in TTHealthWatch: insulin price caps

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation

Diabetes Tied to Higher Death Risk After Solid Organ Transplant

Mortality was worse for those with pre-existing and new-onset diabetes

Less Than 1% of Hypertension Cases Screened for Primary Aldosteronism

Real-world study turned up a "meaningful" 8.7% positive rate

FDA Clears First OTC Continuous Glucose Monitor for Kids

Authorization of Stelo integrated CGM extends to children without diabetes as well

COVID Shots Tied to Lower Risks of Heart Attack, Cardiac Death

Three studies suggest that getting a COVID vaccine is still beneficial for adults

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds

"It would be exciting if these medications were truly bone protective," says researcher

Teplizumab Approval Expands to Early Type 1 Diabetes

Product aims to disrupt the autoimmune attack against insulin-producing beta cells

Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up

Mortality linked to second-generation Sapien XT in intermediate surgical risk cohort

PAs in Cardiology; Increased Risks With Gout; Bad News for Female Heart Recipients

Recent developments of interest in cardiovascular medicine

Recommended News For You

Combination therapy improves outcomes for advanced triple-negative breast cancer

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

Stem Cell Selection Unneeded for SSc Transplant Therapy?

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Ranking of the Best US Hospitals for Psychiatric Care.

Why are so many young adults getting cancer?

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Healthy Hematopoietic Aging and Disease Avoidance: Mechanisms, Clinical Insights, and Future Directions 

Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking Charge of Your Cancer Journey.

2.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

5.

"We Caught It Early": Advantage or Disadvantage?

1.

How HLH is Revolutionizing Healthcare

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot